ВИЧ и СПИД: ожидается полсотни новых лекарств и вакцин
Американские биофармацевтические компании вовсю прорабатывают вопрос терапии и профилактики этого инфекционного заболевания.
- Facebook
- VK
- Twitter
- Instagram
- Telegram
- Google
Антиретровирусные/антивирусные ПрепаратПодробностиРазработчикНазначениеСтатус ALT-803IL-15 super agonist protein complexAltor BioScienceHIV infection treatmentPhase I APH-0812PKC modulator/HDAC inhibitorAphiosHIV latency combination treatmentPhase I bictegravir/F/TAFnon-boosted integrase inhibitor/emtricitabine/tenofovir alafenamideGilead SciencesHIV-1 infection treatmentPhase III cabotegravir LAHIV integrase inhibitor (long-acting intramuscular injection)ViiV HealthcareHIV infection PrEPPhase III cabotegravir LA/rilpivirine LA combinationHIV integrase inhibitor and NNRTI (long-acting intramuscular injection)Janssen Research & Development, ViiV HealthcareHIV infection treatmentPhase III cenicrivirocCCR2/CCR5 receptor antagonistTobira TherapeuticsHIV-1 infection adjunctive carePhase II dapivirine vaginal ringNNRTIInternational Partnership for MicrobicidesHIV infection preventionPhase I darunavir STRdarunavir/cobicistat/emtricitabine/tenofovir alafenamide fixed-dose combinationJanssen Research & DevelopmentHIV-1 infection treatment/pediatric treatmentPhase III/Phase I Descovy®emtricitabine/tenofovir alafenamideGilead SciencesHIV-1 infection PrEPPhase III dolutegravir/lamivudineHIV integrase inhibitor/NRTI fixed-dose combinationViiV HealthcareHIV infection treatmentPhase III dolutegravir/rilpivirine STR Janssen Research & Development, ViiV HealthcareHIV infection treatment (treatment experienced)application submitted doravirine (MK-1439)NNRTIMerck & Co.HIV-1 infection treatment (treatment-naïve)Phase III doravirine/lamivudine/tenofovir disoproxil fumarate Merck & Co.HIV-1 infection treatment (treatment-naïve)Phase III Edurant LA®rilpivirine long-acting nanosuspension for injectionJanssen Research & DevelopmentHIV infection treatmentPhase I elsulfavirineNNRTIViriomHIV infection PrEP, PEP & treatment (sustained-release oral)Phase II fostemsavirattachment inhibitorViiV HealthcareHIV-1 infection treatmentPhase III vesatolimod (GS-9620) Gilead SciencesHIV infection treatmentPhase I GSK2838232HIV maturation inhibitorGlaxoSmithKlineHIV-1 infection treatmentPhase I ibalizumabviral entry inhibitorUS TaiMed BiologicsHIV-1 infection treatmentapplication submitted IRT-101methionine enkephalinCytocomHIV infection treatmentPhase II MB66 microbicidemonoclonal antibodiesMapp BiopharmaceuticalHIV infection preventionPhase I MIV 150/zinc acetatevaginal gelPopulation CouncilHIV infection preventionPhase I MK-8591NRTIMerck & Co.HIV-1 infection treatment (ART-treatment-naïve)Phase I Prezcobix®cobicistat/darunavirJanssen Research & DevelopmentHIV-1 infection pediatric treatmentPhase I PRO 140viral entry inhibitorCytoDynHIV infection treatmentPhase III Reyataz®atazanavirBristol-Myers SquibbHIV-1 infection pediatric treatmentPhase III RPI-MNmodified cobratoxin/nicotinic receptor antagonist/interferon gamma stimulantReceptoPharmHIV infection treatmentPhase I completed tenofovir gelNtRTICONRADHIV infection preventionPhase II TMB-607HIV protease inhibitorTaiMed BiologicsHIV infection treatmentPhase I Vitekta®elvitegravirGilead SciencesHIV-1 infection pediatric treatmentPhase II/III VM1500aNNRTIViriomHIV infection PrEP, PEP & treatment (long-acting injectable)Phase I VRC01LSCD4 antigen inhibitor mAbNational Institute of Allergy and Infectious Diseases, XencorHIV infection treatmentPhase I Клеточная/генная терапия ПрепаратПодробностиРазработчикНазначениеСтатус CAL-1stem cell gene therapyCalimmuneHIV-1 infection (one-time treatment)Phase I/II SB-728-HSPCZFN-mediated genome editing T-cellsSangamo TherapeuticsHIV infection treatmentPhase I/II SB-728-TZFN-mediated genome editing in HSCsSangamo TherapeuticsHIV infection treatmentPhase II StealthVector® HGTV43™antisense HIV-1 therapyEnzo TherapeuticsHIV-1 infection treatmentPhase II Вакцины ПрепаратПодробностиРазработчикНазначениеСтатус AGS-004autologous dendritic cell vaccineArgos Therapeutics, University of North CarolinaHIV-1 infection treatment (with vorinostat)Phase I DNA-CDNA HIV vaccineNational Institute of Allergy and Infectious DiseasesHIV infection prevention (combination with other HIV vaccines)Phase I/II GOVX-B11clade-B DNA HIV vaccineGeoVax LabsHIV infection preventionPhase II HIV vaccineAd26 Mos HIV trivalent vaccineJanssen Vaccines and PreventionHIV infection preventionPhase II HIV vaccineAd26 Mos4 HIV vaccineJanssen Vaccines and PreventionHIV infection preventionPhase II HIV vaccineMVA mosaic HIV vaccineJanssen Vaccines and PreventionHIV infection preventionPhase I/II HIV vaccineviral vector prime & rgp 120 boost vaccineSanofiHIV infection preventionPhase II HIV vaccine Ad4-CladeC PaxVaxHIV infection preventionPhase I HIV vaccine Ad4-mGag PaxVaxHIV infection preventionPhase I HIVAX™replication-defective HIV vaccineGeneCure BiotechnologiesHIV-1 infection treatmentPhase I IHV001subunit HIV vaccineProfectus BiosciencesHIV infection preventionPhase I ITV-1inactivated pepsin fractionImmunotech LaboratoriesHIV infection treatmentPhase II PBSVax™HIV-MAG DNA vaccineProfectus BiosciencesHIV infection prevention and treatmentPhase I PENNVAX®-GPclade A, B, C, D HIV vaccineInovio PharmaceuticalsHIV infection prevention and treatmentPhase I Remune®GP120-depleted HIV-1 vaccineImmune Response BioPharmaHIV-1 infection adult and pediatric treatmentapplication submitted RemuneX®HIV combination vaccineImmune Response BiopharmaHIV-1 infection treatmentPhase III
Юлия Стрельцова
Научный эксперт R&A-офиса Mosmedpreparaty.ru.
Дополнительная информация о Юлии и ее контактные данные доступны в разделе «Научно-исследовательский офис».
